Jill M. Ray
Keine laufenden Positionen mehr
Profil
Jill M.
Ray is Vice President of Research and Development for Capital Genomix, Inc. She worked with the Extracellular Matrix Pathology Section in the Laboratory of Pathology in NCI at the National Institutes of Health.
Dr. Ray joined KPL in 1996.
She worked at Oncor, Inc. Dr. Ray has 24 years of experience in the fields of molecular and cellular biology and biochemistry and 18 years experience with analysis of gene expression.
She received a BA degree in Biology from Boston University in 1982 and PhD from The University of Virginia in 1988.
Ehemalige bekannte Positionen von Jill M. Ray
| Unternehmen | Position | Ende |
|---|---|---|
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - |
Oncor, Inc.
 Oncor, Inc. Medical SpecialtiesHealth Technology Oncor, Inc. markets a variety of molecular biology products, including restriction enzymes and markets related apparatus and equipment. The company was founded in July 1983 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | - |
Capital Genomix, Inc.
 Capital Genomix, Inc. Medical SpecialtiesHealth Technology Capital Genomix, Inc. develops and markets novel antibody based therapeutics. The firm possesses two genomic and proteomic drug development technology platforms, GeneSystem320 and ImmunoMouse. The company was founded in August 2000 and is headquartered in Gaithersburg, MD. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Jill M. Ray
| Boston University | Undergraduate Degree |
| University of Virginia | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Capital Genomix, Inc.
Capital Genomix, Inc. Medical SpecialtiesHealth Technology Capital Genomix, Inc. develops and markets novel antibody based therapeutics. The firm possesses two genomic and proteomic drug development technology platforms, GeneSystem320 and ImmunoMouse. The company was founded in August 2000 and is headquartered in Gaithersburg, MD. | Health Technology |
National Institutes of Health
National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Government |
Oncor, Inc.
Oncor, Inc. Medical SpecialtiesHealth Technology Oncor, Inc. markets a variety of molecular biology products, including restriction enzymes and markets related apparatus and equipment. The company was founded in July 1983 and is headquartered in Gaithersburg, MD. | Health Technology |